Importance of toll-like receptor 9 in host defense against M1T1 group a streptococcus infections

Journal of Innate Immunity

Volumn 4, Issue 2, 2012, Pages 213-218

  Zinkernagel, Annelies S ^a,e   Hruz, Petr ^c   Uchiyama, Satoshi ^a,e   Von Köckritz Blickwede, Maren ^a,f   Schuepbach, Reto A ^d,e   Hayashi, Tomoko ^c   Carson, Dennis A ^c   Nizet, Victor ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Group A Streptococcus; Innate immunity; Toll like receptor 9

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GROUP A STREPTOCOCCAL INFECTION; HOST RESISTANCE; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

ANIMALS; BLOTTING, WESTERN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TOLL-LIKE RECEPTOR 9;

EID: 84857784859     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000329550     Document Type: Article

References (34)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685-694. (Pubitemid 41505357)
2. Loof TG, Goldmann O, Gessner A, Herwald H, Medina E: Aberrant inflammatory response to Streptococcus pyogenes in mice lacking myeloid differentiation factor 88. Am J Pathol 2010; 176: 754-763.
3. Hakansson A, Bentley CC, Shakhnovic EA, Wessels MR: Cytolysin-dependent evasion of lysosomal killing. Proc Natl Acad Sci USA 2005; 102: 5192-5197.
4. Osterlund A, Engstrand L: Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol 1995; 115: 685-688.
5. Osterlund A, Engstrand L: An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium -studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol 1997; 117: 883-888. (Pubitemid 27521369)
6. Thulin P, Johansson L, Low DE, Gan BS, Kotb M, McGeer A, Norrby-Teglund A: Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006; 3:e53.
7. Hertzen E, Johansson L, Wallin R, Schmidt H, Kroll M, Rehn AP, Kotb M, Morgelin M, Norrby-Teglund A: M1 protein-dependent intracellular trafficking promotes persistence and replication of Streptococcus pyogenes in macrophages. J Innate Immun 2010; 2: 534-545.
8. Medina E, Goldmann O, Toppel AW, Chhatwal GS: Survival of Streptococcus pyogenes within host phagocytic cells: A pathogenic mechanism for persistence and systemic invasion. J Infect Dis 2003; 187: 597-603. (Pubitemid 36250023)
9. Staali L, Morgelin M, Bjorck L, Tapper H: Streptococcus pyogenes expressing M and Mlike surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 2003; 5: 253-265. (Pubitemid 36511572)
10. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745. (Pubitemid 32015992)
11. Huang LY, Aliberti J, Leifer CA, Segal DM, Sher A, Golenbock DT, Golding B: Heatkilled Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J Immunol 2003; 171: 1441-1446. (Pubitemid 36900078)
12. Bhan U, Trujillo G, Lyn-Kew K, Newstead MW, Zeng X, Hogaboam CM, Krieg AM, Standiford TJ: Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect Immun 2008; 76: 2895-2904.
13. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM: TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173: 1179-1183. (Pubitemid 38924294)
14. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007; 9: 633-644. (Pubitemid 46231970)
15. Sjolinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR: Important role for Tolllike receptor 9 in host defense against meningococcal sepsis. Infect Immun 2008; 76: 5421-5428.
16. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT: Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 2002; 169: 3970-3977.
17. Wieland CW, Florquin S, van der Poll T: Tolllike receptor 9 is not important for host defense against Haemophilus influenzae. Immunobiology 2010; 215: 910-914.
18. Talati AJ, Kim HJ, Kim YI, Yi AK, English BK: Role of bacterial DNA in macrophage activation by group B streptococci. Microbes Infect 2008; 10: 1106-1113.
19. Gratz N, Siller M, Schaljo B, Pirzada ZA, Gattermeier I, Vojtek I, Kirschning CJ, Wagner H, Akira S, Charpentier E, Kovarik P: Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chem 2008; 283: 19879-19887.
20. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M: Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68: 3523-3534. (Pubitemid 30340453)
21. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, Nizet V, Eckmann L: NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci USA 2009; 106: 12873-12878.
22. Wu CC, Hayashi T, Takabayashi K, Sabet M, Smee DF, Guiney DD, Cottam HB, Carson DA: Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand. Proc Natl Acad Sci USA 2007; 104: 3990-3995. (Pubitemid 47181566)
23. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS: HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005; 115: 1806-1815. (Pubitemid 40979719)
24. Zinkernagel AS, Peyssonnaux C, Johnson RS, Nizet V: Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis 2008; 197: 214-217. (Pubitemid 351263439)
25. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, Turner CE, Mishalian I, Sriskandan S, Hanski E, Nizet V: The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 2008; 4: 170-178.
26. Wagner H: The immunobiology of the TLR9 subfamily. Trends Immunol 2004; 25: 381-386. (Pubitemid 38780955)
27. Goldmann O, Rohde M, Chhatwal GS, Medina E: Role of macrophages in host resistance to group A streptococci. Infect Immun 2004; 72: 2956-2963. (Pubitemid 38542426)
28. Goldmann O, von Kockritz-Blickwede M, Holtje C, Chhatwal GS, Geffers R, Medina E: Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun 2007; 75: 4148-4157. (Pubitemid 47206314)
29. Nizet V, Johnson RS: Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009; 9: 609-617.
30. Albiger B, Dahlberg S, Henriques-Normark B, Normark S: Role of the innate immune system in host defence against bacterial infections: Focus on the Toll-like receptors. J Intern Med 2007; 261: 511-528. (Pubitemid 46835986)
31. Spirig R, Djafarzadeh S, Regueira T, Shaw SG, von Garnier C, Takala J, Jakob SM, Rieben R, Lepper PM: Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions. PLoS One 2010; 5:e0010983.
32. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V: Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 2007; 178: 7516-7519. (Pubitemid 46898018)
33. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M: NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453: 807-811. (Pubitemid 351793778)
34. Lee KS, Scanga CA, Bachelder EM, Chen Q, Snapper CM: TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell Immunol 2007; 245: 103-110. (Pubitemid 46921170)